Trapzyme as multimodal Janus nanoplatform for apoptosis-based immunotherapy of periodontitis

Trapzyme作为一种多模式Janus纳米平台,用于基于细胞凋亡的牙周炎免疫疗法

阅读:1

Abstract

Accumulation of pro-inflammatory macrophages caused by apoptosis deficiency is a major contributing factor for periodontitis progression. Inducing apoptosis of these macrophages is thus a promising approach for periodontitis management but faces multiple challenges including off-target effects, bacterial infection, redox imbalance and pro-inflammatory stimulus. Herein, we present a multimodal nanoplatform, termed Trapzyme, comprising a gelatin-bilirubin conjugate core and a macrophage membrane shell functionalized with photosensitizer cyanidin 3-O-glucoside-iron coordination and macrophage-targeting ligand phosphoethanolamine-polyethylene glycol-folate. With this design, Trapzyme is found to function as smart "iron trap" for infection control by leveraging bacterial siderophilic behavior. Upon near-infrared (NIR) irradiation, it enhances bacterial eradication via oxidative stress mechanism while inducing mild photothermal stress to trigger lysosome-mediated apoptosis in pro-inflammatory macrophages. Notably, Trapzyme is endowed with potent reactive oxygen species scavenging activity for rapid restoration of extracellular and intracellular redox balance after phototherapy. This NIR-switchable Janus-faced redox activity of Trapzyme synergically contributes to macrophage homeostasis with its neutralization of pro-inflammatory factors. Due to these multifaceted functions, NIR-tunable Trapzyme delivered by microneedles shows favorable efficacy in periodontal remodeling in mice with periodontitis, providing a precise, programmable and effective strategy for apoptosis-based immunotherapy of periodontitis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。